Colorectal Carcinoma
|
1962
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.900 |
0.945 |
55 |
2007 |
2019 |
Prostate carcinoma
|
1168
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.800 |
0.871 |
31 |
2007 |
2019 |
Malignant neoplasm of prostate
|
1082
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.800 |
0.857 |
28 |
2007 |
2017 |
Malignant tumor of colon
|
688
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.770 |
1.000 |
21 |
2007 |
2019 |
Colorectal Neoplasms
|
609
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.730 |
1.000 |
17 |
2007 |
2019 |
Malignant Neoplasms
|
1641
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.100 |
1.000 |
16 |
2008 |
2018 |
Primary malignant neoplasm
|
1374
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.100 |
1.000 |
16 |
2008 |
2018 |
Malignant neoplasm of colon and/or rectum
|
502
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.100 |
0.933 |
15 |
2007 |
2019 |
Adenocarcinoma of large intestine
|
432
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.700 |
1.000 |
14 |
2007 |
2019 |
COLORECTAL CANCER, SUSCEPTIBILITY TO, 1
|
374
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.700 |
1.000 |
14 |
2007 |
2019 |
COLORECTAL CANCER, SUSCEPTIBILITY TO, 10
|
370
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.700 |
1.000 |
14 |
2007 |
2019 |
COLORECTAL CANCER, SUSCEPTIBILITY TO, 12
|
373
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.700 |
1.000 |
14 |
2007 |
2019 |
COLORECTAL CANCER, SUSCEPTIBILITY TO, 3
|
368
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.700 |
1.000 |
14 |
2007 |
2019 |
Malignant neoplasm of large intestine
|
375
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.700 |
1.000 |
14 |
2007 |
2019 |
Neoplasms
|
1644
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.080 |
0.875 |
8 |
2009 |
2018 |
Adenoma of large intestine
|
213
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.760 |
0.857 |
7 |
2010 |
2019 |
Colon Carcinoma
|
275
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.070 |
1.000 |
7 |
2008 |
2013 |
Malignant neoplasm of thyroid
|
103
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.050 |
1.000 |
5 |
2012 |
2017 |
Thyroid carcinoma
|
145
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.050 |
1.000 |
5 |
2012 |
2017 |
Thyroid Neoplasm
|
135
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.050 |
1.000 |
5 |
2012 |
2017 |
Breast Carcinoma
|
2793
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.040 |
0.750 |
4 |
2008 |
2016 |
Carcinoma of lung
|
1204
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.040 |
1.000 |
4 |
2008 |
2017 |
Malignant neoplasm of breast
|
3417
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.040 |
0.750 |
4 |
2008 |
2016 |
Malignant neoplasm of lung
|
1142
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.040 |
1.000 |
4 |
2008 |
2017 |
Primary malignant neoplasm of lung
|
981
|
0.578 |
0.440 |
8 |
127401060 |
non coding transcript exon variant |
G/T
|
snv |
|
0.37
|
0.040 |
1.000 |
4 |
2008 |
2017 |